<DOC>
	<DOCNO>NCT01051284</DOCNO>
	<brief_summary>People pancreatic cancer cure surgery ask participate study . The purpose study test ability radiation oncologists administer Cyberknife therapy along Gemcitabine chemotherapy patient pancreatic cancer . Radiation Gemcitabine effective kill cancer cell generally give time . Cyberknife therapy highly focused radiation use extensively Georgetown University around United States treat number cancer . It believe Cyberknife highly focus give safely regular dos chemotherapy attack cancer cell two way time . This research do know use Cyberknife chemotherapy safe way treat pancreatic cancer .</brief_summary>
	<brief_title>A Study Gemcitabine Cyberknife Radiation Therapy Pancreatic Cancer</brief_title>
	<detailed_description>This single arm , open-label pilot study Cyberknife plus Gemcitabine 10 patient locally advanced pancreatic cancer receive prior local systemic therapy pancreatic cancer .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Histologically proven unresectable , nonmetastatic pancreatic adenocarcinoma measurable evaluable disease without involvement duodenum Performance Status 02 No prior anticancer therapy pancreatic adenocarcinoma No prior anticancer therapy kind within last 5 year Adequate hepatic , bone marrow , renal function Life expectance &gt; 12 week Women childbearing potential must negative serum pregnancy test Duodenal involvement pancreatic cancer Metastatic cancer Active severe infection , know chronic infection HIV , hepatitis B virus , hepatitis C virus Cardiovascular disease include unstable angina , therapy lifethreatening ventricular arrhythmia , myocardial infarction , stroke , congestive heart failure within last 6 month Lifethreatening visceral disease severe concurrent disease Pregnant breastfeeding Anticipated patient survival 3 month Another active malignancy within past 5 year except cervical cancer situ , situ carcinoma bladder nonmelanoma carcinoma skin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Pancreas</keyword>
	<keyword>Newly diagnose</keyword>
	<keyword>Cyberknife</keyword>
	<keyword>Gemcitabine</keyword>
</DOC>